Tarbox Family Office’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Tarbox Family Office’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-54	Closed	-$3K	–	663
2017 Q4	$3K	Hold	54	–	–	﹤0.01%	468
2017 Q3	$3K	Hold	54	–	–	﹤0.01%	464
2017 Q2	$3K	Hold	54	–	–	﹤0.01%	451
2017 Q1	$3K	Buy	+54	New	+$2.66K	﹤0.01%	451

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Tarbox Family Office's BIVV Position: Q1 2018 in Review

Tarbox Family Office sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 54 shares — an estimated $3K sold.

Tarbox Family Office first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $3K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Tarbox Family Office reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Tarbox Family Office sold 54 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $3K.
Tarbox Family Office first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Tarbox Family Office's Bioverativ Inc. Common Stock position peaked at $3K in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Tarbox Family Office's 13F filing for Q1 2018, filed 25 Apr 2018.